Document Detail

Stem cell therapy to treat heart ischaemia: implications for diabetes cardiovascular complications.
MedLine Citation:
PMID:  25344789     Owner:  NLM     Status:  In-Data-Review    
Diabetes mellitus is a well-known risk factor for coronary artery disease (CAD), which can lead to acute myocardial infarction, chronic myocardial ischaemia and heart failure. Despite the advantages in medical treatment, percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), morbidity and mortality is still high in patients with CAD. Along with PCI and CABG or in patients without options for revascularization, stem cell regenerative therapy in controlled trials is a possibility. Stem cells are believed to exert their actions by angiogenesis and regeneration of cardiomyocytes. Recently published clinical trials and meta-analysis of stem cell studies have shown encouraging results with increased left ventricle ejection fraction and reduced symptoms in patients with CAD and heart failure. There is some evidence of mesenchymal stem cell being more effective compared to other cell types and cell therapy may be more effective in patients with known diabetes mellitus. However, further investigations are warranted.
Abbas Ali Qayyum; Anders Bruun Mathiasen; Jens Kastrup
Related Documents :
7082499 - Electrophysiological effects of sotalol--just another beta blocker?
3973259 - Spatial variation of qt intervals in normal persons and patients with acute myocardial ...
18388029 - Qt dispersion and left ventricular hypertrophy in elderly hypertensive and normotensive...
10526689 - Relation of ventricular repolarization to cardiac cycle length in normal subjects, hype...
16246959 - Global dynamic coupling of activation and repolarization in the human ventricle.
15944809 - Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolari...
19318149 - Assessment of fetal cardiac function before and after therapy for twin-to-twin transfus...
312129 - Clinical and angiographic determinants of early mortality related to aortocoronary bypa...
19734999 - Cardiotoxicity induced by tyrosine kinase inhibitors.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current diabetes reports     Volume:  14     ISSN:  1539-0829     ISO Abbreviation:  Curr. Diab. Rep.     Publication Date:  2014 Dec 
Date Detail:
Created Date:  2014-10-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101093791     Medline TA:  Curr Diab Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  554     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Interleukin 2 in the pathogenesis and therapy of type 1 diabetes.
Next Document:  Glucagon and type 2 diabetes: the return of the alpha cell.